The Middle East stock markets have recently faced downward pressure, with most Gulf bourses retreating amid escalating US-Iran hostilities and heightened geopolitical tensions affecting investor sentiment. Despite these challenges, the region remains a fertile ground for investment opportunities, particularly in small-cap stocks that exhibit strong fundamentals and resilience in volatile conditions.
| Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
|---|---|---|---|---|
| Dana Gas PJSC | 7.67% | 3.20% | 0.91% | ★★★★★★ |
| Al-Babtain Power and Telecommunications | 68.69% | 15.27% | 47.38% | ★★★★★☆ |
| Burjeel Holdings | 84.25% | 10.35% | 9.42% | ★★★★★☆ |
| Specialized Medical | 52.90% | 7.46% | 23.05% | ★★★★☆☆ |
| Maharah for Human Resources | 33.21% | 18.87% | 9.29% | ★★★★☆☆ |
Let's explore several standout options from the results in the screener.
Simply Wall St Value Rating: ★★★★★☆
Overview: Burjeel Holdings PLC, with a market cap of AED5.41 billion, operates multi-specialty hospitals and medical centers across the United Arab Emirates, the Sultanate of Oman, and the Kingdom of Saudi Arabia.
Operations: The primary revenue streams for Burjeel Holdings come from its hospitals and medical centers, generating AED5.03 billion and AED482.07 million respectively. The company also has a pharmacy segment contributing AED63.24 million to the total revenue.
Burjeel Holdings is making waves in the healthcare sector with its focus on high-value specialties like oncology and fertility, driving a remarkable 73.3% earnings growth over the past year, outpacing the industry average of 4.2%. Despite a high net debt to equity ratio of 72.7%, Burjeel's debt has significantly decreased from 1760.5% to 84.3% over five years, indicating improved financial health. The company recently reported first-quarter sales of AED1,338 million and net income of AED49 million, showing solid performance despite competitive pressures and regulatory risks in its aggressive expansion strategy across new markets.
Simply Wall St Value Rating: ★★★★★★
Overview: Dana Gas PJSC, along with its subsidiaries, operates in the exploration, production, transportation, processing, distribution, marketing, and sale of natural gas and petroleum-related products across the United Arab Emirates, Iraq, and Egypt with a market capitalization of AED6.35 billion.
Operations: Dana Gas generates revenue primarily from its integrated oil and gas operations, amounting to $352 million.
Dana Gas PJSC, a prominent player in the Middle East's energy sector, is making strides with its recent drilling success in Egypt. The company has fully settled overdue receivables and continues to receive timely payments from the Egyptian Government. With cash exceeding total debt and a reduced debt-to-equity ratio from 8% to 7.7% over five years, Dana Gas is financially robust. The company's earnings grew by 3.2% last year, outperforming the industry average of -0.3%. Trading at 54.1% below estimated fair value, it presents an attractive opportunity for investors seeking undervalued assets with growth potential.
Gain insights into Dana Gas PJSC's past trends and performance with our Past report.
Simply Wall St Value Rating: ★★★★☆☆
Overview: Specialized Medical Company owns and operates hospitals, clinics, and medical centers in the Kingdom of Saudi Arabia with a market capitalization of SAR4.02 billion.
Operations: Specialized Medical generates revenue primarily from its medical services, contributing SAR1.27 billion, and pharmacies & others segment, adding SAR284.49 million.
Specialized Medical is making waves with a notable project award from the Saudi Ministry of Health to manage the SABIC Behavioral Care Specialist Hospital, valued at SAR 3.8 billion. This aligns well with their recent performance, where earnings surged by 62.5% over the past year, outpacing industry growth of 1.1%. The company's debt-to-equity ratio has improved significantly from 72.7% to 52.9% in five years, yet it remains high at 42%. With net income rising to SAR 32.55 million this quarter compared to SAR 29.64 million last year, Specialized Medical appears poised for continued growth and stability in its sector.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com